Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin
- PMID: 6120812
Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin
Abstract
An investigation of the effects of the liposome variables (size, surface area, and amount of injected lipid) on the intramuscular absorption and subsequent lymphatic uptake of drug from the injection site (left muscle) and in the opposite (right) muscle and lymph node was done in mice. Two size ranges were studied (0.3-2.0 mu and 0.15-0.7 mu). Large multilamellar vesicles were studied at lipid doses of 20.7 and 9.0 mg/kg, whereas small multilamellar vesicles were investigated at a dose of 9.5 mg/kg. Liposomes were composed of phosphatidylcholine/cholesterol/phosphatidylserine/alpha-tocopherol/14C-dipalmitoylphosphatidylcholine (as a marker for the lipid phase), 4:5:1:0.01:0.01 (molar ratio). 3H-inulin was used to monitor the aqueous phase. At 24 hr after administration, large liposomes tended to result in the largest fraction of drug at the injection site, with the 3H/14C ratio indicating stability of the remaining vesicles. Small liposomes showed a greater uptake of inulin via the lymphatics. Decreasing the total amount of injected lipid resulted in a slower absorption of large liposomes and a greater uptake via the lymphatics.
Similar articles
-
Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.J Microencapsul. 1995 Jul-Aug;12(4):437-46. doi: 10.3109/02652049509087256. J Microencapsul. 1995. PMID: 8583318
-
The effect of route of administration on the disposition of inulin encapsulated in multilamellar vesicles of defined particle size.Res Commun Chem Pathol Pharmacol. 1980 Feb;27(2):293-304. Res Commun Chem Pathol Pharmacol. 1980. PMID: 7367749
-
Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.Cancer Res. 1981 Apr;41(4):1311-7. Cancer Res. 1981. PMID: 7214320
-
Liposomes to target the lymphatics by subcutaneous administration.Adv Drug Deliv Rev. 2001 Aug 23;50(1-2):143-56. doi: 10.1016/s0169-409x(01)00154-5. Adv Drug Deliv Rev. 2001. PMID: 11489337 Review.
-
Drug depots in lymph nodes: which carrier is most appropriate?J Microencapsul. 1991 Jan-Mar;8(1):103-19. doi: 10.3109/02652049109021864. J Microencapsul. 1991. PMID: 1880687 Review.
Cited by
-
Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration - effect of lipid composition.Pharm Res. 1985 Nov;2(6):271-8. doi: 10.1023/A:1016337500364. Pharm Res. 1985. PMID: 24271123
-
In vitro-in vivo myotoxicity of intramuscular liposomal formulations.Pharm Res. 1996 Sep;13(9):1384-8. doi: 10.1023/a:1016082218942. Pharm Res. 1996. PMID: 8893279
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials